Page last updated: 2024-09-03

caprylates and sincalide

caprylates has been researched along with sincalide in 1 studies

Compound Research Comparison

Studies
(caprylates)
Trials
(caprylates)
Recent Studies (post-2010)
(caprylates)
Studies
(sincalide)
Trials
(sincalide)
Recent Studies (post-2010) (sincalide)
5,0611002,3394,01572533

Protein Interaction Comparison

ProteinTaxonomycaprylates (IC50)sincalide (IC50)
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.0006
Cholecystokinin receptor type AHomo sapiens (human)0.0006
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.001
Gastrin/cholecystokinin type B receptorMus musculus (house mouse)0.0008
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)0.0004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cox, JE; Kelm, GR; Meller, ST; Randich, A; Spraggins, DS1

Other Studies

1 other study(ies) available for caprylates and sincalide

ArticleYear
Jejunal or portal vein infusions of lipids increase hepatic vagal afferent activity.
    Neuroreport, 2001, Oct-08, Volume: 12, Issue:14

    Topics: Action Potentials; alpha-Linolenic Acid; Animals; Appetite Regulation; Caprylates; Corn Oil; Jejunum; Lipid Metabolism; Lipids; Liver; Male; Portal Vein; Rats; Rats, Sprague-Dawley; Sincalide; Vagus Nerve; Visceral Afferents

2001